Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-137.9%
operating margin TTM
-138.0%
revenue TTM
230.74 Million
revenue per share TTM
2.6$
valuation ratios | |
|---|---|
| pe ratio | -5.04 |
| peg ratio | -0.51 |
| price to book ratio | 27.44 |
| price to sales ratio | 7.42 |
| enterprise value multiple | -5.22 |
| price fair value | 27.44 |
profitability ratios | |
|---|---|
| gross profit margin | 92.24% |
| operating profit margin | -138.0% |
| pretax profit margin | -137.45% |
| net profit margin | -137.9% |
| return on assets | -54.12% |
| return on equity | -1091.45% |
| return on capital employed | -81.8% |
liquidity ratio | |
|---|---|
| current ratio | 2.08 |
| quick ratio | 2.04 |
| cash ratio | 0.29 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 125.10 |
| operating cycle | 167.55 |
| days of payables outstanding | 474.87 |
| cash conversion cycle | -307.32 |
| receivables turnover | 8.60 |
| payables turnover | 0.77 |
| inventory turnover | 2.92 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.68 |
| debt equity ratio | 6.80 |
| long term debt to capitalization | 0.84 |
| total debt to capitalization | 0.87 |
| interest coverage | -28.78 |
| cash flow to debt ratio | -0.59 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.97 |
| cash per share | 4.46 |
| operating cash flow per share | -2.86 |
| free cash flow operating cash flow ratio | 1.04 |
| cash flow coverage ratios | -0.59 |
| short term coverage ratios | -3.46 |
| capital expenditure coverage ratio | -24.63 |
Frequently Asked Questions
When was the last time Travere Therapeutics, Inc. (NASDAQ:TVTX) reported earnings?
Travere Therapeutics, Inc. (TVTX) published its most recent earnings results on 31-10-2024.
What is Travere Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Travere Therapeutics, Inc. (NASDAQ:TVTX)'s trailing twelve months ROE is -1091.45%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Travere Therapeutics, Inc. (TVTX) currently has a ROA of -54.12%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TVTX's net profit margin stand at?
TVTX reported a profit margin of -137.9% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TVTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.08 in the most recent quarter. The quick ratio stood at 2.04, with a Debt/Eq ratio of 6.80.